Sumitomo Mitsui Trust Holdings Inc. boosted its holdings in Agilent Technologies Inc (NYSE:A) by 1.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,246,141 shares of the medical research company’s stock after purchasing an additional 12,083 shares during the quarter. Sumitomo Mitsui Trust Holdings Inc.’s holdings in Agilent Technologies were worth $100,165,000 at the end of the most recent quarter.
Other hedge funds have also added to or reduced their stakes in the company. Captrust Financial Advisors raised its position in Agilent Technologies by 2,121.1% in the 4th quarter. Captrust Financial Advisors now owns 422 shares of the medical research company’s stock valued at $29,000 after purchasing an additional 403 shares during the last quarter. Lake Point Wealth Management acquired a new position in Agilent Technologies in the 4th quarter valued at $30,000. JOYN Advisors Inc. increased its stake in Agilent Technologies by 186.6% in the 4th quarter. JOYN Advisors Inc. now owns 470 shares of the medical research company’s stock valued at $32,000 after buying an additional 306 shares during the period. Destination Wealth Management increased its stake in Agilent Technologies by 100.0% in the 1st quarter. Destination Wealth Management now owns 400 shares of the medical research company’s stock valued at $32,000 after buying an additional 200 shares during the period. Finally, We Are One Seven LLC acquired a new position in Agilent Technologies in the 4th quarter valued at $33,000.
Several equities analysts have issued reports on the stock. Zacks Investment Research cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Thursday, May 16th. Bank of America dropped their price objective on shares of Agilent Technologies from $88.00 to $82.00 and set a “buy” rating on the stock in a research note on Wednesday, May 15th. Deutsche Bank dropped their price objective on shares of Agilent Technologies from $90.00 to $85.00 and set a “buy” rating on the stock in a research note on Wednesday, May 15th. Barclays dropped their price objective on shares of Agilent Technologies from $88.00 to $86.00 and set an “overweight” rating on the stock in a research note on Wednesday, May 15th. Finally, Cowen boosted their price objective on shares of Agilent Technologies from $80.00 to $90.00 and gave the company an “outperform” rating in a research note on Tuesday, March 26th. Three research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $86.58.
In related news, Director Paul N. Clark sold 2,823 shares of the stock in a transaction dated Wednesday, March 27th. The shares were sold at an average price of $80.31, for a total value of $226,715.13. Following the sale, the director now directly owns 88,857 shares of the company’s stock, valued at approximately $7,136,105.67. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, VP Mark Doak sold 16,421 shares of the stock in a transaction dated Friday, February 22nd. The shares were sold at an average price of $77.95, for a total transaction of $1,280,016.95. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 48,583 shares of company stock worth $3,855,924.
Shares of NYSE:A traded down $1.44 on Thursday, reaching $66.53. 142,889 shares of the company were exchanged, compared to its average volume of 2,976,147. The company has a quick ratio of 2.82, a current ratio of 3.41 and a debt-to-equity ratio of 0.35. Agilent Technologies Inc has a 1-year low of $60.42 and a 1-year high of $82.27. The stock has a market cap of $21.69 billion, a PE ratio of 23.82, a price-to-earnings-growth ratio of 1.90 and a beta of 1.33.
Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Tuesday, May 14th. The medical research company reported $0.71 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.72 by ($0.01). Agilent Technologies had a return on equity of 19.71% and a net margin of 22.25%. The company had revenue of $1.24 billion for the quarter, compared to analyst estimates of $1.27 billion. During the same period last year, the company earned $0.65 earnings per share. The business’s revenue for the quarter was up 2.7% compared to the same quarter last year. Equities analysts anticipate that Agilent Technologies Inc will post 3.05 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 24th. Stockholders of record on Tuesday, July 2nd will be paid a dividend of $0.164 per share. This represents a $0.66 dividend on an annualized basis and a dividend yield of 0.99%. Agilent Technologies’s dividend payout ratio (DPR) is presently 23.66%.
TRADEMARK VIOLATION NOTICE: This news story was first reported by Highlight Press and is the property of of Highlight Press. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright laws. The legal version of this news story can be read at https://highlightpress.com/2019/05/23/agilent-technologies-inc-a-stake-increased-by-sumitomo-mitsui-trust-holdings-inc.html.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.